|
Rheumatic Fever is an inflammatory disease, that affects many of the body's connective tissues, especially those of the heart, joints, brain or skin.
Anyone can get acute rheumatic fever, but it usually occurs in children 5 to 15 years old. The rheumatic heart disease that results can last for life.
Follow the links below to find information on rheumatic fever.
Reviewed May 2008
Printer friendly page
| Results 1 to 5 displayed. |
| Title: |
Penicillin for secondary prevention of rheumatic fever
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Rheumatic fever is a rare complication of throat infection, that can damage the heart. People who have had rheumatic fever can suffer from it again following streptococcal throat infection if they do not receive regular penicillin. Penicillin for preven...
|
| Date: |
Apr 2002
|
| Title: |
Anti-inflammatory treatment for carditis in acute rheumatic fever
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Rheumatic fever is a late complication of a type of throat infection caused by streptococcus bacteria. It is an immune system disease that can lead to inflammatory disease of the heart (carditis), joints, brain and skin. Carditis can cause heart failure...
|
| Date: |
Nov 2002
|
| Title: |
Rheumatic heart disease
|
| Publisher: |
Better Health Channel
|
| Description: |
Rheumatic heart disease may develop after repeated or prolonged illness with rheumatic fever, usually during childhood. This condition is characterised by damage to various structures of the heart including the valves, lining or muscle. Rheumatic fever is caused by infection with the Group A streptococcus bacterium.
|
| Date: |
Aug 2007
|
| Title: |
New guidelines for infective endocarditis prophylaxis
|
| Publisher: |
Australian Prescriber
|
| Description: |
Therapeutic Guidelines has revised the guidelines for the use of antibiotics for prophylaxis against infective endocarditis. The major change is that antibiotic prophylaxis is no longer indicated in patients with aortic stenosis, mitral stenosis, or symptomatic or asymptomatic mitral valve prolapse.
|
| Date: |
Dec 2008
|
| Results 1 to 5 displayed. |
|
